Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001703794 | SCV000523617 | likely benign | not provided | 2020-07-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001703794 | SCV001009966 | likely benign | not provided | 2025-01-05 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001841316 | SCV001340871 | likely benign | Cardiac arrhythmia | 2018-07-20 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000425127 | SCV002571060 | likely benign | not specified | 2022-07-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374660 | SCV002685297 | likely benign | Cardiovascular phenotype | 2018-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000425127 | SCV006066459 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000425127 | SCV001922712 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703794 | SCV001968317 | likely benign | not provided | no assertion criteria provided | clinical testing |